Search hospitals > Montana > Anaconda
Community Hospital of Anaconda
Claim this profileAnaconda, Montana 59711
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Recurrence
202 reported clinical trials
2 medical researchers
Summary
Community Hospital of Anaconda is a medical facility located in Anaconda, Montana. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Community Hospital of Anaconda is involved with conducting 202 clinical trials across 386 conditions. There are 2 research doctors associated with this hospital, such as John M. Schallenkamp and Benjamin T. Marchello.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
John M. SchallenkampBenefis Healthcare- Sletten Cancer Institute4 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
177 reported clinical trials
254 drugs studied
Benjamin T. MarchelloKalispell Regional Medical Center8 years of reported clinical research
Studies Breast Cancer
Studies Ovarian Cancer
6 reported clinical trials
20 drugs studied
Clinical Trials running at Community Hospital of Anaconda
Breast Cancer
Cancer
Bladder Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Bladder Carcinoma
Ovarian Cancer
Colon Cancer
Squamous Cell Carcinoma
Oropharyngeal Carcinoma
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Community Hospital of Anaconda?
Community Hospital of Anaconda is a medical facility located in Anaconda, Montana. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Community Hospital of Anaconda is involved with conducting 202 clinical trials across 386 conditions. There are 2 research doctors associated with this hospital, such as John M. Schallenkamp and Benjamin T. Marchello.